ProNAi Therapeutics Inc (DNAI) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 71 transactions totaling $17.6M, demonstrating a bullish sentiment with $16.8M in net insider flow. The most recent transaction on Nov 8, 2016 involved a transaction of 6,767 shares valued at $0.
No significant insider buying has been recorded for DNAI in the recent period.
No significant insider selling has been recorded for DNAI in the recent period.
Based on recent SEC filings, insider sentiment for DNAI is bullish with an Insider Alignment Score of 98/100 and a net flow of $16.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ProNAi Therapeutics Inc (DNAI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading DNAI stock, having executed 71 transactions in the past 90 days. The most active insider is Albert Cha (Executive), who has made 6 transactions totaling $4.3M.
Get notified when executives and directors at DNAI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 8, 2016 | R. Parfet Donald | Executive | Other | 6,767 | $N/A | $0 | |
| Nov 8, 2016 | R. Parfet Donald | Executive | Other | 3,383 | $N/A | $0 | |
| Nov 8, 2016 | R. Parfet Donald | Executive | Other | 1,423 | $N/A | $0 | |
| Nov 8, 2016 | R. Parfet Donald | Executive | Other | 2,403 | $N/A | $0 | |
| Nov 8, 2016 | R. Parfet Donald | Executive | Other | 4,806 | $N/A | $0 | |
| Sep 29, 2016 | R. Parfet Donald | Executive | Other | 1,692 | $N/A | $0 | |
| Sep 29, 2016 | R. Parfet Donald | Executive | Other | 711 | $N/A | $0 | |
| Sep 29, 2016 | R. Parfet Donald | Executive | Other | 3,384 | $N/A | $0 | |
| Sep 29, 2016 | R. Parfet Donald | Executive | Other | 1,202 | $N/A | $0 | |
| Sep 29, 2016 | R. Parfet Donald | Executive | Other | 2,403 | $N/A | $0 | |
| May 13, 2016 | R. Parfet Donald | Executive | Other | 3,204 | $N/A | $0 | |
| Mar 22, 2016 | Chapman Wendy | Executive | Option Exercise | 3,000 | $0.97 | $2.9K | |
| Mar 22, 2016 | Chapman Wendy | Executive | Sale | 3,000 | $7.01 | $21.0K | |
| Feb 22, 2016 | Chapman Wendy | Executive | Sale | 3,000 | $7.06 | $21.2K | |
| Feb 22, 2016 | Chapman Wendy | Executive | Option Exercise | 3,000 | $0.97 | $2.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 7 | $17.2M | 84.0% |
Other(J) | 23 | $2.8M | 13.9% |
Sale(S) | 9 | $405.7K | 2.0% |
Exercise(M) | 5 | $22.8K | 0.1% |
Conversion(C) | 27 | $0 | 0.0% |
Insiders at ProNAi Therapeutics Inc are accumulating shares at an accelerated pace. With 11 insiders making 71 transactions totaling $17.2M in purchases versus $405.7K in sales, the net buying activity of $16.8M signals strong executive confidence. Albert Cha (Executive) leads the buying activity with $4.3M in transactions across all time.